Evidence map›Paper›PMID 17316818›Full record

ReviewProgress in lipid research2007

Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation.

Yeon-Joo Kang, Uri R Mbonye, Cynthia J DeLong, Masayuki Wada, William L Smith

Abstract readReview
In one paragraph

Review in Progress in lipid research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 127 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed, 1 pooled it
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

127 citing papers in PubMed, 1 synthesis or guideline pooled it, 292 citations in OpenAlex.

  1. Prognostic Value of COX-2, NF-κB, and Sp1 Tissue Expressions in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2021
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Recommendations for robust and reproducible research on ferroptosis.Nature reviews. Molecular cell biology · 2025
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Frontiers in pharmacology · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation.International journal of molecular sciences · 2023
    Review
  20. Review

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yeon-Joo KangDepartment of Biological Chemistry, University of Michigan Medical School, 5301 Medical Science Research Building III, Ann Arbor, MI 48109, USA.
Uri R Mbonye
Cynthia J DeLong
Masayuki Wada
William L Smith
University of Michigan–Ann Arbor · USMichigan State University · US

Funding

Catalysis by Prostaglandin Endoperoxide H SynthasesR01GM068848 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SMITH, WILLIAM L · 2003 to 2014
$5.6M
NIGMS NIH HHS GM68848NIGMS NIH HHS R01 GM068848
6 · The paper itself

Abstract

Cyclooxygenases-1 and -2 (COX-1 and -2) catalyze the committed step in prostaglandin formation. Each isozyme subserves different biological functions. This is, at least in part, a consequence of differences in patterns of COX-1 and COX-2 expression. COX-1 is induced during development, and COX-1 mRNA and COX-1 protein are very stable. These latter properties can explain why COX-1 protein levels usually remain constant in those cells that express this isozyme. COX-2 is usually expressed inducibly in association with cell replication or differentiation. Both COX-2 mRNA and COX-2 protein have short half-lives relative to those of COX-1. Therefore, COX-2 protein is typically present for only a few hours after its synthesis. Here we review and develop the concepts that (a) COX-2 gene transcription can involve at least six different cis-acting promoter elements interacting with trans-acting factors generated by multiple, different signaling pathways, (b) the relative contribution of each cis-acting COX-2 promoter element depends on the cell type, the stimulus and the time following the stimulus and (c) a unique 27 amino acid instability element located just upstream of the C-terminus of COX-2 targets this isoform to the ER-associated degradation system and proteolysis by the cytosolic 26S proteasome.

Indexed as

Gene Expression Regulation, EnzymologicAnimalsCyclooxygenase 1Cyclooxygenase 2HumansTranscription, GeneticCyclooxygenase 1Cyclooxygenase 2

Identifiers

PMID17316818
PMCPMC3253738
OpenAlexW2013777179

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.